Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event
- PMID: 20956490
- DOI: 10.1136/hrt.2010.196170
Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event
Abstract
Objective: To compare gender-related lifestyle changes and risk factor management after hospitalisation for a coronary event or revascularisation intervention in Europe.
Method: The EUROASPIRE III survey was carried out in 22 European countries in 2006-2007. Consecutive patients having had a coronary event or revascularisation before the age of 80 were identified. A total of 8966 patients (25.3% women) were interviewed and underwent clinical and biochemical tests at least 6 months after hospital admission. Trends in cardiovascular risk management were assessed on the basis of the 1994-1995, 1999-2000 and 2006-2007 EUROASPIRE surveys.
Results: Female survey participants were generally older and had a lower educational level than male participants (p<0.0001). The prevalences of obesity (p<0.0001), high blood pressure (BP) (p=0.001), elevated low-density lipoprotein (LDL)-cholesterol (p<0.0001) and diabetes (p<0.0001) were significantly higher in women than in men, whereas current smoking (p<0.0001) was significantly more common in men. The use of antihypertensive and antidiabetic drugs (but not that of other drugs) was more common in women than in men. However, BP (p<0.0001), LDL-cholesterol (p<0.0001) and HbA1c (p<0.0001) targets were less often achieved in women than in men. Between 1994 and 2007, cholesterol control improved less in women than in men (interaction: p=0.009), whereas trends in BP control (p=0.32) and glycaemia (p=0.36) were similar for both genders.
Conclusion: The EUROASPIRE III results show that despite similarities in medication exposure, women are less likely than men to achieve BP, LDL-cholesterol and HbA1c targets after a coronary event. This gap did not appear to narrow between 1994 and 2007.
Similar articles
-
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37. doi: 10.1097/HJR.0b013e3283294b1d. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19287307
-
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5. Lancet. 2009. PMID: 19286092
-
[Cardiovascular risk factors and prevention in women: similarities and differences].Ital Heart J Suppl. 2001 Feb;2(2):125-41. Ital Heart J Suppl. 2001. PMID: 11255880 Review. Italian.
-
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.Eur Heart J. 2001 Apr;22(7):554-72. doi: 10.1053/euhj.2001.2610. Eur Heart J. 2001. PMID: 11259143
-
Prehypertension: an opportunity for a new public health paradigm.Cardiol Clin. 2010 Nov;28(4):561-9. doi: 10.1016/j.ccl.2010.07.008. Cardiol Clin. 2010. PMID: 20937441 Review.
Cited by
-
Differences in Risk Factors for Coronary Atherosclerosis According to Sex.J Lipid Atheroscler. 2024 May;13(2):97-110. doi: 10.12997/jla.2024.13.2.97. Epub 2024 Jan 16. J Lipid Atheroscler. 2024. PMID: 38826179 Free PMC article. Review.
-
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with stable chest pain.Coron Artery Dis. 2024 Jun 1;35(4):314-321. doi: 10.1097/MCA.0000000000001339. Epub 2024 Feb 20. Coron Artery Dis. 2024. PMID: 38407435 Free PMC article.
-
Management of Dyslipidemia in Women and Men with Coronary Heart Disease: Results from POLASPIRE Study.J Clin Med. 2021 Jun 11;10(12):2594. doi: 10.3390/jcm10122594. J Clin Med. 2021. PMID: 34208351 Free PMC article.
-
Special Considerations for Lipid-Lowering Therapy in Women Reflecting Recent Randomized Trials.Curr Atheroscler Rep. 2021 Jun 19;23(8):42. doi: 10.1007/s11883-021-00942-3. Curr Atheroscler Rep. 2021. PMID: 34146167 Review.
-
Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients.J Am Heart Assoc. 2020 Dec;9(23):e019628. doi: 10.1161/JAHA.120.019628. Epub 2020 Nov 26. J Am Heart Assoc. 2020. PMID: 33241727 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous